Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity (Q50528009)

14 March 2018

title

Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity (English)

1 reference

14 March 2018

0 references

Micheau O

1

1 reference

14 March 2018

Solary E

2

1 reference

14 March 2018

Hammann A

3

1 reference

14 March 2018

Martin F

4

1 reference

14 March 2018

Dimanche-Boitrel MT

5

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

14 March 2018

Journal of the National Cancer Institute

published in

1 reference

14 March 2018

volume

89

1 reference

14 March 2018

issue

11

1 reference

14 March 2018

page(s)

783-789

1 reference

14 March 2018

Apoptosis induced by anticancer drugs

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

The role of APO-1-mediated apoptosis in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Fas-mediated cytotoxicity by freshly isolated natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Fas-mediated cytotoxicity remains intact in perforin and granzyme B antisense transfectants of a human NK-like cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Monoclonal-antibody-mediated apoptosis in adult T-cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Lethal effect of the anti-Fas antibody in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Functional Consequences of APO-1/Fas (CD95) Antigen Expression by Normal and Neoplastic Hematopoietic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.11.783

21 January 2018

Identifiers

DOI

10.1093/JNCI/89.11.783

1 reference

14 March 2018

1 reference

14 March 2018